Postresuscitation recovery of functional activity of central nervous system in rats during combination treatment with mexidol and neuropeptides delta sleep-inducing peptide and oxytocin.
Gorenkova. N A NA; Nazarenko. I V IV; Volkov. A V AV
Key Findings
- Mexidol, DSIP, and oxytocin each sped up neurological recovery after severe brain‑oxygen loss in rats.
- All three agents also lessened behavioral disturbances linked to mood and motivation.
- The combination of mexidol plus oxytocin produced the strongest overall improvement.
Practical Outcomes
- These results are limited to a rat model of cardiac arrest and do not translate directly to everyday health or performance enhancement. While the study hints that mexidol and oxytocin might protect the brain after acute injury, there is no actionable protocol for healthy individuals or biohackers at this stage.
Summary
In rats that were revived after a 12‑minute heart stoppage, giving the antioxidant drug mexidol together with the neuropeptides delta sleep‑inducing peptide (DSIP) or oxytocin helped the brain recover faster and reduced emotional and motivational problems. The best results were seen when mexidol was paired with oxytocin.
Abstract
In experiments on rats we studied the effects of antioxidant and membrane-protecting agent mexidol and neuropeptides delta sleep-inducing peptide and oxytocin administered during resuscitation after 12-min clinical death. Individual and combination treatment with these substances accelerated recovery of the neurological status and partially or completely corrected behavioral disorders associated with changes in the emotional and motivational status. Combined administration of mexidol and oxytocin most significantly promoted postresuscitation recovery of functional activity in the central nervous system.
Study Information
pubmed
2003
10.1023/b:bebm.0000010948.51981.fb